chevron_leftBack
As of 24 April 2025, Yunnan Baiyao Group Co.,Ltd has a market cap of $14.12B USD, ranking #1272 globally and #149 in China. It ranks #108 in the Healthcare sector, and #13 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$14.12BUSD
102.86B CNY
Enterprise Value
$12.29BUSD
89.58B CNY
Revenue (TTM)
$5.49BUSD
40.03B CNY
EBITDA (TTM)
$660.45MUSD
4.81B CNY
Net Income (TTM)
$651.77MUSD
4.75B CNY
EBITDA Margin
12%
Profit Margin
12%
PE Ratio
21.7
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Ming Dong
open_in_new
Employees
9,277
Founded
1902
Website
yunnanbaiyao.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.8% | 0.6% | 5% | 1.6% | 0.2% | 2.5% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
000538
云南白药集团股份有限公司 Class A
ISIN: CNE0000008X7
Shares Out.:
Shares Outstanding:
1.769B1
Shares Float:
1.769B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
57.61 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Yunnan Baiyao Group Co.,Ltd
Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally. It provides health products; drugs; medical devices; traditional Chinese medicine resources; and tea products. The company also supplies and distributes medicines. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.
